Furthermore, JAK2-activating mutation has been observed in chronic myeloproliferative neoplasms (MPNs), such as chronic myeloid leukemia (CML), polycythemia vera and myelofibrosis [36,37]. The gene discussed is JAK2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.